Analysts at Citigroup bowed to the uncertainty surrounding Boston Scientific’s (NYSE:BSX) immediate financial future, delivering a downgrade to its stock rating as headwinds in its cardiac business are complicated by its recovery from a major cyberattack last month. Citi’s researchers have lowered their estimates for the company eight times so far this year, most recently […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Autonomix taps former Medtronic FDA counsel head for board of directors
Autonomix Medical (Nasdaq:AMIX) has tapped Medtronic’s former chief regulatory counsel, Sandra Cohen Kalter, for its board of directors as it looks to advance its pipeline of catheters for mapping and treating the nervous system. Kalter has served as an advisor to Autonomix’s board for nearly a year. Now with her own seat, the company hopes […]
Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
While some industry watchers have declared Medtronic’s (NYSE:MDT) recent marquee investment in Cornerstone Robotics a sign of wavering confidence in its homegrown Hugo platform, analysts say a closer look holds the potential of a broader customer base and stronger strategic position. In a note to investors, Needham & Co. analysts agreed with Medtronic’s pitch that […]
Johnson & Johnson drops LAA assets following suspended pivotal study
Johnson & Johnson MedTech (NYSE:JNJ) is offloading a left-atrial appendage closure system it paid $400 million upfront for nearly three years ago, abandoning plans to compete in the space dominated by Boston Scientific and Abbott. Acquired through its late-2023 buy of the developer Laminar, J&J’s Biosense Webster then backed a pivotal study that sought to […]
Medtronic hires former Recor CEO to run interventional cardiology group
Medtronic (NYSE:MDT) has hired former Recor Medical President and CEO Lara Barghout as president of the Interventional Cardiology Therapies (ICT) operating unit. The ICT business covers minimally invasive therapies in structural heart, coronary, and hypertension management, the last of which includes renal denervation (RDN). Watch on-demand: The 2026 MDO Min-Vasive Medtech webinar series Recor Medical won […]
Dexcom CFO to expand into COO role
Dexcom‘s (Nasdaq:DXCM) C-suite is seeing another of its members take on multiple roles. Its chief financial officer will now also serve as chief operating officer. Jereme Sylvain joined the diabetes tech company in 2018, and has been its CFO and executive VP since 2021. His new COO hat will add oversight of Dexcom’s global operations […]
Medtronic moves to divest final stake in MiniMed
Medtronic (NYSE: MDT) is entering the final stretch of its long-running plan to split from its diabetes technology business, with the launch of an exchange offer that will allow stockholders to swap their company shares for those of the independent MiniMed (Nasdaq: MMED). With its catalog of insulin pumps, continuous glucose monitors and other diabetes […]
Meet Conor Hale, MassDevice’s new senior editor
My name is Conor Hale, and I’m happy to introduce myself as MassDevice and Medical Design & Outsourcing’s new senior editor. I’ve had the pleasure of covering medical technology and the life sciences for the past 15 years from the Washington, D.C. area, at outlets including The Cancer Letter and FDAnews. Most recently, I spent […]
Johnson & Johnson MedTech reportedly could sell DePuy Synthes to Apollo
Johnson & Johnson MedTech (NYSE: JNJ) is in talks with Apollo Global Management to sell all or part of its DePuy Synthes orthopedics business, according to media reports citing anonymous sources. A Bloomberg report said discussions involved the orthopedics unit, while The Wall Street Journal specifically mentioned the hips and knees business. The deal would […]
Boston Scientific continues to make progress on cyberattack recovery
Boston Scientific (NYSE: BSX) announced on LinkedIn that it has now fully restored manufacturing, order fulfillment and shipping operations after a cybersecurity incident identified on Aug. 25. In the LinkedIn post, out yesterday, the Marlborough, Massachusetts–based minimally invasive medtech company said: “As order processing continues, we are working to fulfill customer orders as quickly as […]
Edwards Lifesciences, Medtronic score CMS win for TAVR
Edwards Lifesciences (NYSE: EW) and Medtronic (NYSE: MDT) are among the medtech companies praising CMS’s decision to expand Medicare coverage for TAVR to people with asymptomatic severe aortic stenosis. The finalized national coverage decision, published yesterday evening, also removes the evidence development (CED) requirement for symptomatic cases. In addition, CMS plans to review the evidence […]
